Cargando…
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19 and the current standard care relies on supportive treatments. Therefore, based on the fast and global spread of the virus, urgent investigations are warranted in order to develop preventive and therapeutic drugs...
Autores principales: | Catanzaro, Michele, Fagiani, Francesca, Racchi, Marco, Corsini, Emanuela, Govoni, Stefano, Lanni, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255975/ https://www.ncbi.nlm.nih.gov/pubmed/32467561 http://dx.doi.org/10.1038/s41392-020-0191-1 |
Ejemplares similares
-
Targeting dementias through cancer kinases inhibition
por: Fagiani, Francesca, et al.
Publicado: (2020) -
(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis
por: Fagiani, Francesca, et al.
Publicado: (2021) -
The Peptidyl-prolyl Isomerase Pin1 in Neuronal Signaling: from Neurodevelopment to Neurodegeneration
por: Fagiani, Francesca, et al.
Publicado: (2020) -
Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2
por: Fagiani, Francesca, et al.
Publicado: (2020) -
Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea
por: Catanzaro, Michele, et al.
Publicado: (2018)